Difference between revisions of "Glycopyrrolate"
From WikiAnesthesia
(Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = }} Provide a brief summary of this dr...") |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 2: | Line 2: | ||
| trade_names = | | trade_names = | ||
| drug_class = | | drug_class = | ||
| drug_class_color = | | drug_class_color = anticholinergic | ||
| uses = | | uses = | ||
| contraindications = | | contraindications = | ||
| routes = | | routes = | ||
| dosage = | | dosage = | ||
| dosage_calculation = glycopyrrolate | |||
}} | }} | ||
Glycopyrrolate is an anticholinergic drug commonly used in anesthesia to treat bradycardia and decrease secretions. It notably does not cross the blood-brain barrier and consequently has very few central effects. | |||
== Uses<!-- Describe uses of the drug. If appropriate, add subsections for each indication. --> == | == Uses<!-- Describe uses of the drug. If appropriate, add subsections for each indication. --> == | ||
* Treat reflex bradycardia due to vasovagal reactions | |||
* Reduce secretions (salivary, tracheobronchial, pharyngeal) | |||
* Use in conjunction with neostigmine to prevent neostigmine's muscarinic effects such as bradycardia in neuromuscular blocking reversal | |||
== Contraindications<!-- List contraindications and precautions for use of the drug. --> == | == Contraindications<!-- List contraindications and precautions for use of the drug. --> == | ||
Latest revision as of 05:20, 30 September 2024
Glycopyrrolate
| Clinical data | |
| Dosage | |
| Pharmacodynamics | |
| Pharmacokinetics | |
| Physical and chemical data | |
| Article quality | |
| Editor rating | |
|---|---|
| User likes | 1 |
Glycopyrrolate is an anticholinergic drug commonly used in anesthesia to treat bradycardia and decrease secretions. It notably does not cross the blood-brain barrier and consequently has very few central effects.
Uses
- Treat reflex bradycardia due to vasovagal reactions
- Reduce secretions (salivary, tracheobronchial, pharyngeal)
- Use in conjunction with neostigmine to prevent neostigmine's muscarinic effects such as bradycardia in neuromuscular blocking reversal
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Olivia Sutton and Chris Rishel